Quality of Life with Ribociclib Versus Abemaciclib as First-Line Treatment of Hr+/Her2-Advanced Breast Cancer: a Matching-Adjusted Indirect Comparison
AuthID
P-00Y-443
P-00Y-443
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service